An advertisement promoting the Eucerin Hyaluron-Filler Epigenetic Serum has been prohibited due to deceptive assertions regarding its anti-ageing capabilities. The £49 product claimed to make users appear “up to five years younger,” a statement that raised significant concerns from the Advertising Standards Authority (ASA) regarding its validity.
Concerns Over Study Methodology
The ASA’s scrutiny stemmed from the clinical study cited by the manufacturer, Beiersdorf, which involved 160 participants over a four-week period. The study’s methodology was called into question, particularly as it relied heavily on self-reported data. This subjective nature of the feedback rendered the results questionable, as participants were asked to evaluate their perceived age reduction after using the serum.
Beiersdorf defended its position, stating that the phrase “up to” was intended to indicate a genuine maximum result rather than an expected average outcome. The company maintains that its products are backed by scientific research. However, the ASA highlighted significant flaws in the study, including the absence of a control group and insufficient details regarding participant recruitment.
Additional Evidence Under Scrutiny
Further complicating the matter, the ASA noted that the serum was tested in a climate distinct from that of the UK, potentially affecting its efficacy. Beiersdorf submitted three other pieces of evidence to support its claims, all of which were not published in peer-reviewed journals. The ASA found each piece of evidence lacking credibility, with one cited study focusing on the active ingredient but not specifically on the serum itself.
As a result, the advertising watchdog concluded that the claims made in the advertisement were misleading. Beiersdorf confirmed that the billboard advertisement, which had been displayed at London’s Balham tube station, was no longer active in the UK.
The Bigger Picture: Misleading Beauty Claims
The cosmetics industry has faced increasing scrutiny for making exaggerated claims regarding product effectiveness. Aesthetics marketing expert Lianne Sykes emphasised the importance of ethical advertising practices, urging companies to conduct thorough skin analyses over extended periods to substantiate any claims. Sykes advised consumers to be discerning, encouraging them to ask critical questions about how skin quality is assessed and whether products are tested across diverse age groups.
“Good skin often results from a combination of healthy habits rather than relying solely on a single product,” she noted, highlighting the need for consumer awareness in the face of appealing branding and high-profile endorsements.
Why it Matters
The ASA’s decision underscores the growing demand for transparency in the beauty industry, especially as consumers increasingly seek products that deliver on their promises. Misleading advertisements not only undermine consumer trust but also set unrealistic beauty standards. This case serves as a reminder for both companies and consumers to engage in informed practices that prioritise integrity and authenticity in the advertising of cosmetic products.